Follicum is a pharmaceutical company. The greatest focus is on the development of drug candidates that stimulate hair growth in patients. Currently products are held that may stimulate hair growth, but also hamper the degree of hair growth, mainly derived from hirsutism, which implicates unusually large production of hair in women. The pharmaceutical consists of endogenous, human proteins, which influence the processing of hair follicles. The company was established in 2011 and is based in Lund.

Quotes for Follicum AB

Right Now

+/-
-0.138
%
-15,54%
Latest
0.75
High
0.91
Low
0.646
Volume
4 137 443
Turnover (SEK)
2 968 488
Value (MSEK)
61,3

Board

CEO

  • Kim Arvid Nielsen

Chairman Of The Board

  • Gun-Britt Fransson

Board

  • Alejandra Mørk
  • Anders Månsson
  • Carl-Johan Spak
  • Lars H. Bruzelius

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 8,05 8,05 2021-03-31
Recipharm Venture Fund AB 5,34 5,34 2021-03-31
Nordnet Pensionsförsäkring 5,25 5,25 2021-03-31
Mats Paulssons Stiftelse För Forskning Innovation Samhällsbygg 3,92 3,92 2021-03-31
Brushamn Invest AB 3,42 3,42 2021-03-31
Tibia Konsult AB 3,38 3,38 2021-03-31
Mats Lundberg 2,67 2,67 2021-03-31
Rothesay Ltd 2,45 2,45 2020-10-30
Nordic Cross Asset Management 2,18 2,18 2021-05-31
Pia Althin 2,02 2,02 2021-03-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading